Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of the heart in Duchenne muscular dystrophy.

× No keyword cloud information.

13 in total

Review 1. Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors: Suzanne E Berry
Journal: Stem Cells Transl Med Date: 2014-11-12 Impact factor: 6.940

2. Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.

Authors: Nalinda B Wasala; Jin-Hong Shin; Yi Lai; Yongping Yue; Federica Montanaro; Dongsheng Duan
Journal: Hum Gene Ther Date: 2018-03-22 Impact factor: 5.695

Review 3. Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy.

Authors: Dongsheng Duan
Journal: Hum Mol Genet Date: 2006-10-15 Impact factor: 6.150

4. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.

Authors: Nalinda B Wasala; Brian Bostick; Yongping Yue; Dongsheng Duan
Journal: Hum Mol Genet Date: 2013-03-03 Impact factor: 6.150

5. Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.

Authors: Christine Péladeau; Aatika Ahmed; Adel Amirouche; Tara E Crawford Parks; Lucas M Bronicki; Vladimir Ljubicic; Jean-Marc Renaud; Bernard J Jasmin
Journal: Hum Mol Genet Date: 2015-10-22 Impact factor: 6.150

6. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Authors: Ju Lan Chun; Robert O'Brien; Min Ho Song; Blake F Wondrasch; Suzanne E Berry
Journal: Stem Cells Transl Med Date: 2012-12-27 Impact factor: 6.940

7. Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.

Authors: Suzanne E Berry; Peter Andruszkiewicz; Ju Lan Chun; Jun Hong
Journal: Stem Cells Transl Med Date: 2013-09-25 Impact factor: 6.940

8. Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice.

Authors: Brian Bostick; Yongping Yue; Chun Long; Nate Marschalk; Deborah M Fine; Jing Chen; Dongsheng Duan
Journal: Mol Ther Date: 2008-12-09 Impact factor: 11.454

9. Cardiomyopathy in the mouse model of Duchenne muscular dystrophy caused by disordered secretion of vascular endothelial growth factor.

Authors: Dariusz Nowak; Hanna Kozlowska; Jerzy S Gielecki; Jan Rowinski; Anna Zurada; Krzysztof Goralczyk; Wladimir Bozilow
Journal: Med Sci Monit Date: 2011-11

10. Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice.

Authors: Lawrence T Bish; Mark Yarchoan; Meg M Sleeper; Jeffrey A Gazzara; Kevin J Morine; Pedro Acosta; Elisabeth R Barton; H Lee Sweeney
Journal: PLoS One Date: 2011-06-22 Impact factor: 3.240